Shuoshi Biotech announced that the company previously controlled the voting rights of its shares by controlling Taizhou Shuokang and Taizhou Shuoyuan. The two partnership companies completed business changes. The executive partners were all changed from Fang Yongsheng to Liang Kecheng, and the concerted action relationship was terminated. Fang Yongsheng's total voting rights over the company's shares changed from 32.24% to 28.43%; the actual number of shares held by each entity has not changed, and the company's controlling shareholders and actual controllers have not changed.

Shuoshi Biotech announced that the company previously controlled the voting rights of its shares by controlling Taizhou Shuokang and Taizhou Shuoyuan. The two partnership companies completed business changes. The executive partners were all changed from Fang Yongsheng to Liang Kecheng, and the concerted action relationship was terminated. Fang Yongsheng's total voting rights over the company's shares changed from 32.24% to 28.43%; the actual number of shares held by each entity has not changed, and the company's controlling shareholders and actual controllers have not changed.